A new study published in the JAMA Psychiatry gives the strongest evidence that semaglutide — the active ingredient in Ozempic and the weight-loss drug Wegovy — could genuinely help individuals struggling with alcohol addiction drink less and crave alcohol less frequently.

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern California looked at a positive side

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just curb their desire to eat; for some, they also lead them to drink less alcohol.

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings,

Novo Nordisk A/S’s Ozempic helped reduce alcohol cravings in a small study, more evidence that the popular injections may help people cut down on drinking.